IOVA
Price
$3.90
Change
+$0.17 (+4.56%)
Updated
Mar 11 closing price
Capitalization
1.28B
62 days until earnings call
MLYS
Price
$14.30
Change
-$0.65 (-4.34%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
712.9M
68 days until earnings call
Ad is loading...

IOVA vs MLYS

Header iconIOVA vs MLYS Comparison
Open Charts IOVA vs MLYSBanner chart's image
Iovance Biotherapeutics
Price$3.90
Change+$0.17 (+4.56%)
Volume$8.03M
Capitalization1.28B
Mineralys Therapeutics
Price$14.30
Change-$0.65 (-4.34%)
Volume$27.67K
Capitalization712.9M
IOVA vs MLYS Comparison Chart
Loading...
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IOVA vs. MLYS commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IOVA is a Hold and MLYS is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (IOVA: $3.90 vs. MLYS: $14.93)
Brand notoriety: IOVA and MLYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IOVA: 78% vs. MLYS: 2266%
Market capitalization -- IOVA: $1.28B vs. MLYS: $712.9M
IOVA [@Biotechnology] is valued at $1.28B. MLYS’s [@Biotechnology] market capitalization is $712.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IOVA’s FA Score shows that 0 FA rating(s) are green whileMLYS’s FA Score has 0 green FA rating(s).

  • IOVA’s FA Score: 0 green, 5 red.
  • MLYS’s FA Score: 0 green, 5 red.
According to our system of comparison, both IOVA and MLYS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IOVA’s TA Score shows that 3 TA indicator(s) are bullish while MLYS’s TA Score has 5 bullish TA indicator(s).

  • IOVA’s TA Score: 3 bullish, 4 bearish.
  • MLYS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MLYS is a better buy in the short-term than IOVA.

Price Growth

IOVA (@Biotechnology) experienced а -0.51% price change this week, while MLYS (@Biotechnology) price change was +67.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.43%. For the same industry, the average monthly price growth was -8.50%, and the average quarterly price growth was -7.70%.

Reported Earning Dates

IOVA is expected to report earnings on May 13, 2025.

MLYS is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (+0.43% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IOVA($1.28B) has a higher market cap than MLYS($713M). MLYS YTD gains are higher at: 21.284 vs. IOVA (-47.297). MLYS has higher annual earnings (EBITDA): -168.35M vs. IOVA (-388.32M). IOVA has more cash in the bank: 397M vs. MLYS (264M). IOVA has higher revenues than MLYS: IOVA (90.9M) vs MLYS (0).
IOVAMLYSIOVA / MLYS
Capitalization1.28B713M179%
EBITDA-388.32M-168.35M231%
Gain YTD-47.29721.284-222%
P/E RatioN/AN/A-
Revenue90.9M0-
Total Cash397M264M150%
Total Debt78.9MN/A-
FUNDAMENTALS RATINGS
IOVA: Fundamental Ratings
IOVA
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IOVAMLYS
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
88%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBFIX20.25N/A
N/A
Federated Hermes Global Allocation IS
MIZIX8.45N/A
N/A
MassMutual International Eq I
OPMYX30.91-0.08
-0.26%
Invesco Main Street Mid Cap Y
MCVIX30.47-0.30
-0.97%
MFS Mid Cap Value I
DDICX14.54-0.15
-1.02%
Macquarie Wealth Builder C

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with PTGX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then PTGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
+41.92%
PTGX - MLYS
48%
Loosely correlated
+45.79%
CKPT - MLYS
43%
Loosely correlated
+61.52%
ABOS - MLYS
37%
Loosely correlated
-4.00%
CELC - MLYS
34%
Loosely correlated
-3.38%
IOVA - MLYS
34%
Loosely correlated
-0.27%
More